4 results match your criteria: "Weill Cornell Medical College and The Methodist Hospital[Affiliation]"
Retina
January 2014
Retina Consultants of Houston, Weill Cornell Medical College and The Methodist Hospital, Houston, Texas.
Purpose: To compare the sensitivity of commonly used time-domain (TD-OCT) and spectral-domain optical coherence tomography platforms and scanning modalities in the management of neovascular age-related macular degeneration in a population with a high prevalence of exudative disease activity.
Methods: Fifty consecutive patients within the prospective SAVE (Super-dose Anti-Vascular Endothelial growth factor) trial, which analyzed the utility of 2.0 mg intravitreal ranibizumab for the treatment of recalcitrant neovascular age-related macular degeneration, were enrolled in a comparison trial of 3 different optical coherence tomography (OCT) platforms.
Int J Cardiovasc Imaging
February 2012
Office of the Dean and Department of Radiology, Weill Cornell Medical College and The Methodist Hospital, Houston, Texas, USA.
In a multi-center trial, gadolinium enhanced magnetic resonance angiography (MRA) for diagnosis of acute pulmonary embolism (PE) had a high rate of technically inadequate images. Accordingly, we evaluated the reasons for poor quality MRA of the pulmonary arteries in these patients. We performed a retrospective analysis of the data collected in the PIOPED III study.
View Article and Find Full Text PDFArch Pathol Lab Med
April 2009
Department of Radiology, Weill Cornell Medical College and The Methodist Hospital, Houston, Texas, USA.
Radiology
March 2008
Weill Cornell Medical College and the Methodist Hospital, 6565 Fannin St, Houston, TX 77030, USA.
Purpose: To use Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II data to retrospectively determine sensitivity and specificity of ventilation-perfusion (V/Q) scintigraphic studies categorized as pulmonary embolism (PE) present or PE absent and the proportion of patients for whom these categories applied.
Materials And Methods: The PIOPED II study had institutional review board approval at all participating centers. Patient informed consent was obtained; the study was HIPAA compliant.